Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
580 participants
INTERVENTIONAL
2004-08-31
2006-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GALIDA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men or women who are ³18 years of age
* Female patients: postmenopausal, hysterectomized, or if of childbearing potential, using a reliable method of birth control
* Diagnosed with type 2 diabetes
* Treated with diet alone or treatment with a single oral antidiabetic agent or low doses of two oral antidiabetic agents
Exclusion Criteria
* New York Heart Association heart failure Class III or IV
* Treatment with chronic insulin
* History of hypersensitivity or intolerance to any peroxisome proliferator-activated receptor agonist (like Actos or Avandia), fenofibrate, metformin or 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin)
* History of drug-induced myopathy or drug-induced creatine kinase elevation, liver enzyme elevations, neutropenia (low white blood cells)
* Creatinine levels above twice the normal range
* Creatine kinase above 3 times the upper limit of normal
* Received any investigational product in other clinical studies within 12 weeks
* Any clinically significant abnormality identified on physical examination, laboratory tests or electrocardiogram, which in the judgment of the investigator would compromise the patient's safety or successful participation in the clinical study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
AstraZeneca Galida Medical Science Director, MD
Role: STUDY_DIRECTOR
AstraZeneca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Birmingham, Alabama, United States
Research Site
Columbiana, Alabama, United States
Research Site
Mobile, Alabama, United States
Research Site
Carlisle, Arizona, United States
Research Center
Sherwood, Arizona, United States
Research Site
Chula Vista, California, United States
Research Site
Escondido, California, United States
Research Site
Huntington Beach, California, United States
Research Site
Los Angeles, California, United States
Research Site
Mission Viejo, California, United States
Research Site
Orange, California, United States
Research Site
Pasadena, California, United States
Research Site
Pomona, California, United States
Research Site
Redondo Beach, California, United States
Research Site
Sacramento, California, United States
Research Site
Colorado Springs, Colorado, United States
Research Site
Wheat Ridge, Colorado, United States
Research Site
Clearwater, Florida, United States
Research Site
Gainesville, Florida, United States
Research Site
Hollywood, Florida, United States
Research Site
Jacksonville, Florida, United States
Research Site
Miami, Florida, United States
Research Site
West Palm Beach, Florida, United States
Research Site
Atlanta, Georgia, United States
Research Site
Brunswick, Georgia, United States
Research Site
Carollton, Georgia, United States
Research Site
Honolulu, Hawaii, United States
Research Site
Boise, Idaho, United States
Research Site
Evansville, Indiana, United States
Research Site
Kansas City, Kansas, United States
Research Site
Overland Park, Kansas, United States
Research Site
Witchita, Kansas, United States
Research Site
Bossier City, Louisiana, United States
Research Site
New Orleans, Louisiana, United States
Research Site
Baltimore, Maryland, United States
Research Site
Kalamazoo, Missouri, United States
Research Site
Las Vegas, Nevada, United States
Research Site
Hamilton, New Jersey, United States
Research Site
Albuquerque, New Mexico, United States
Research Site
Albany, New York, United States
Research Site
New York, New York, United States
Research Site
Pahrump, New York, United States
Research Site
Rochester, New York, United States
Research Site
The Bronx, New York, United States
Research Site
White Plains, New York, United States
Research Site
Charlotte, North Carolina, United States
Research Site
Cincinnati, Ohio, United States
Research Site
Dayton, Ohio, United States
Research Site
Kettering, Ohio, United States
Research Site
Oklahoma City, Oklahoma, United States
Research Site
Medford, Oregon, United States
Research Site
Philadelphia, Pennsylvania, United States
Research Site
Simpsonville, South Carolina, United States
Research Site
Morristown, Tennessee, United States
Research Site
Corpus Christi, Texas, United States
Research Site
Dallas, Texas, United States
Research Site
Lubbock, Texas, United States
Research Site
San Antonio, Texas, United States
Research Site
Burke, Virginia, United States
Research Site
Norfolk, Virginia, United States
Research Site
Richmond, Virginia, United States
Research Site
Tacoma, Washington, United States
Research Site
Menomonee Falls, Wisconsin, United States
Research Site
Milwaukee, Wisconsin, United States
Research Site
Hämeenlinna, , Finland
Research Site
Helsinki, , Finland
Research Site
Joensuu, , Finland
Research Site
Kouvola, , Finland
Research Site
Kuopio, , Finland
Research Site
Mikkeli, , Finland
Research Site
Oulu, , Finland
Research Site
Salo, , Finland
Research Site
Tampere, , Finland
Research Site
Vantaa, , Finland
Research Site
Aschaffenburg, , Germany
Research Site
Bad Segeberg, , Germany
Research Site
Beckum, , Germany
Research Site
Berlin, , Germany
Research Site
Dresden, , Germany
Research Site
Ehrenberg, , Germany
Research Site
Essen, , Germany
Research Site
Feldafing, , Germany
Research Site
Hamburg, , Germany
Research Site
Hanover, , Germany
Research Site
Hermaringen, , Germany
Research Site
Künzing, , Germany
Research Site
Langen, , Germany
Research Site
Mannheim, , Germany
Research Site
Marl, , Germany
Research Site
Nuremberg, , Germany
Research Site
Pirna, , Germany
Research Site
Rotenburg/Fulda, , Germany
Research Site
Ashkelon, , Israel
Research Site
Haifa, , Israel
Research Site
Holon, , Israel
Research Site
Jerusalem, , Israel
Research Site
Rishon LeZiyyon, , Israel
Research Site
Safed, , Israel
Research Site
Tel Aviv, , Israel
Research Site
Beek en Donk, , Netherlands
Research Site
Bennebroe, , Netherlands
Research Site
Deurne, , Netherlands
Research Site
Huizen, , Netherlands
Research Site
Losser, , Netherlands
Research Site
Nijverdal, , Netherlands
Research Site
Rijswijk, , Netherlands
Research Site
Roelofarendsveen, , Netherlands
Research Site
Rotterdam, , Netherlands
Research Site
The Hague, , Netherlands
Research Site
Bergen, , Norway
Research Site
Oslo, , Norway
Research Site
Østerås, , Norway
Research Site
San Vicente de Raspeig, Alicante, Spain
Research Site
Villar del Arzobispo, Valencia, Spain
Research Site
Alzira (Valencia), , Spain
Research Site
Barcelona, , Spain
Research Site
Begonte (Lugo), , Spain
Research Site
Madrid, , Spain
Research Site
Seville, , Spain
Research Site
Aberdeen, , United Kingdom
Research Site
Ayr, , United Kingdom
Research Site
Bath, , United Kingdom
Research Site
Berks, , United Kingdom
Research Site
Bucks, , United Kingdom
Research Site
Coventry, , United Kingdom
Research Site
Dundee, , United Kingdom
Research Site
Glasgow, , United Kingdom
Research Site
Manchester, , United Kingdom
Research Sites
Northampton, , United Kingdom
Research Site
Wiltshire, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D6160C00029
Identifier Type: -
Identifier Source: org_study_id